Jul 20, 2026 07:00AM
Jul 20, 2026 07:00AM
Jul 13, 2026 07:00AM
Jul 13, 2026 07:00AM
Jun 23, 2026 07:01AM
Jun 23, 2026 07:00AM
May 13, 2026 04:30PM Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update
May 7, 2026 07:00AM
May 7, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM
Mar 25, 2026 04:05PM
Mar 19, 2026 07:02AM
Mar 19, 2026 07:00AM Armata Pharmaceuticals Delays Announcement of Fourth Quarter and Full-Year 2025 Results and Provides Corporate Update
Feb 23, 2026 07:01AM
Feb 23, 2026 07:00AM
Jan 13, 2026 07:00AM
Jan 13, 2026 07:00AM
Nov 18, 2025 07:00AM
Nov 12, 2025 04:05PM
Nov 10, 2025 07:04AM Armata opens manufacturing facility in Los Angeles
Nov 10, 2025 07:00AM
Oct 22, 2025 11:10AM
Oct 22, 2025 11:10AM
Aug 12, 2025 04:05PM
May 20, 2025 06:39AM
May 14, 2025 04:05PM
May 1, 2025 07:03AM Armata Pharma (ARMP) Receives $4.65M of Additional Non-Dilutive Award Funding from the U.S. DoD to Support Ongoing diSArm Trial of AP-SA02
May 1, 2025 07:00AM
Mar 20, 2025 05:56PM
Mar 12, 2025 05:09PM
Mar 12, 2025 05:08PM
Nov 13, 2024 04:05PM
Nov 12, 2024 07:00AM
Jul 12, 2024 08:17AM H.C. Wainwright Reiterates Buy Rating on Armata Pharmaceuticals (ARMP)
Jul 11, 2024 07:00AM
Aug 2, 2023 04:05PM
Aug 1, 2022 08:00AM
Aug 1, 2022 08:00AM
Feb 22, 2022 08:02AM
Feb 22, 2022 08:00AM
Nov 18, 2021 08:10AM Armata Pharma (ARMP) Provides Regulatory and Clinical Update Reflecting Sustained Progress Across Key Phage Therapeutic Development Programs
Nov 18, 2021 08:00AM
Mar 18, 2021 04:05PM
Jan 27, 2021 07:01AM
Nov 12, 2020 04:05PM
Oct 29, 2020 07:55AM
Oct 29, 2020 07:30AM
Oct 15, 2020 07:32AM Armata Pharma (ARMP) Announces Clearance of IND Application to Initiate Phase 1b/2a Clinical Trial of Lead Candidate AP-PA02 in Pseudomonas aeruginosa Infections
Oct 15, 2020 07:30AM

326,853 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All